Clearside Biomedical files Form 25 to complete Nasdaq delisting after Chapter 11 bankruptcy

Clearside Biomedical, Inc.

Filed Form 25 on Dec 8, 2025 to delist from Nasdaq and deregister under Section 12(b); effective no earlier than Dec 18, 2025.
Nasdaq delisting notice received Nov 24, 2025 after Chapter 11 filing (Case No. 25-12109); trading suspended Dec 1, 2025.
Common stock trades on OTC Pink under symbol CLSDQ since Dec 1, 2025.
Deregistration will reduce SEC reporting obligations 90 days after Form 25 effective date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.